From early design through regulatory approval, Vastrax provides a comprehensive suite of global CRO services to fill critical gaps where you need them most. Our team is obsessed with advancing Neuro Technologies on a Global Scale.
Our team brings decades of neurovascular trial experience to assist in refining protocols, selecting endpoints, and preparing regulatory packages.
Vastrax provides comprehensive design input that reduces risk and positions trials for faster approvals.
With extensive US and EU experience, Vastrax guides sponsors through various regulatory interactions.
Our leadership team meets frequently with regulatory agencies to proactively plan for program success, giving our sponsors the confidence they crave.
Sponsors gain access to elite investigators and veteran coordinators at established global sites that keep trials on track with quality data.
Vastrax accelerates site selection and enrollment through our long-standing relationships enabled by our focus on neuro.
We focus on efficiency, precision, and accountability. Our team oversees all program phases with clear timelines and consistent communication.
Our program launch phase has clear milestones, detailed site feasibility, efficient contracting, and ethics committee submissions delivered with speed and care to accelerate timelines.
Vastrax designs efficient analysis plans and proactively manages complex datasets with speed, transparency, and accuracy. The result is faster database locks and reliable data for confident decision making.
Our integration of AI-enabled insights provides a deep understanding of program trends, allowing our staff to be laser focused on priority areas in large multinational programs.
Vastrax research associates are strategically selected across global regions, averaging 15+ years of experience, ensuring quality data through consistent oversight.
Our safety team safeguards subject well-being and ensures regulatory compliance and data integrity.
Our team leverages decades of indication experience, technical expertise, long-standing investigator relationships, strategic partnerships, and experience that generates value for our clients.
Ischemic, hemorrhagic, and neuroprotective programs, including landmark thrombectomy & aspiration.
Flow-diversion and embolic device advancements that have shaped interventional care.
Small-molecule, biologic, and gene-based treatments advancing neurological health.
Also known as Brain-Machine Interface (BMI), our experts have run landmark programs & published multiple defining essays.
With the advancements in Artificial Intelligence, AI-powered diagnostic imaging is a growing part of our field.
Neuromodulation, robotics, spine, & micro-access tools redefining procedural accuracy.
